 | • レポートコード：MRC2312MG08046 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、66ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のcGMPプラスミド市場規模と予測を収録しています。・世界のcGMPプラスミド市場：売上、2018年-2023年、2024年-2029年 ・世界のcGMPプラスミド市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のcGMPプラスミド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「標準」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 cGMPプラスミドのグローバル主要企業は、Aldevron、 Thermo Fisher、 GenScript ProBio、 Charles River、 WuXi Biologics、 Esco Aster、 VGXI、 Akron Bio、 Andelyn Biosciences、 Waisman Biomanufacturing、 PackGeneなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、cGMPプラスミドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のcGMPプラスミド市場：タイプ別、2018年-2023年、2024年-2029年 世界のcGMPプラスミド市場：タイプ別市場シェア、2022年 ・標準、超高純度 世界のcGMPプラスミド市場：用途別、2018年-2023年、2024年-2029年 世界のcGMPプラスミド市場：用途別市場シェア、2022年 ・DNAワクチン、商用ウイルスベクター製造 世界のcGMPプラスミド市場：地域・国別、2018年-2023年、2024年-2029年 世界のcGMPプラスミド市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるcGMPプラスミドのグローバル売上、2018年-2023年 ・主要企業におけるcGMPプラスミドのグローバル売上シェア、2022年 ・主要企業におけるcGMPプラスミドのグローバル販売量、2018年-2023年 ・主要企業におけるcGMPプラスミドのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Aldevron、 Thermo Fisher、 GenScript ProBio、 Charles River、 WuXi Biologics、 Esco Aster、 VGXI、 Akron Bio、 Andelyn Biosciences、 Waisman Biomanufacturing、 PackGene ************************************************************* ・調査・分析レポートの概要 cGMPプラスミド市場の定義 市場セグメント 世界のcGMPプラスミド市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のcGMPプラスミド市場規模 世界のcGMPプラスミド市場規模：2022年 VS 2029年 世界のcGMPプラスミド市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのcGMPプラスミドの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のcGMPプラスミド製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：標準、超高純度 cGMPプラスミドのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：DNAワクチン、商用ウイルスベクター製造 cGMPプラスミドの用途別グローバル売上・予測 ・地域別市場分析 地域別cGMPプラスミド市場規模 2022年と2029年 地域別cGMPプラスミド売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Aldevron、 Thermo Fisher、 GenScript ProBio、 Charles River、 WuXi Biologics、 Esco Aster、 VGXI、 Akron Bio、 Andelyn Biosciences、 Waisman Biomanufacturing、 PackGene ... |
This research report provides a comprehensive analysis of the cGMP Plasmid market, focusing on the current trends, market dynamics, and future prospects. The report explores the global cGMP Plasmid market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of cGMP Plasmid, challenges faced by the industry, and potential opportunities for market players.
The global cGMP Plasmid market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The cGMP Plasmid market presents opportunities for various stakeholders, including DNA Vaccine, Commercial Virus Vector Manufacturing. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in cGMP Plasmid market. Additionally, the growing consumer demand present avenues for market expansion.
The global cGMP Plasmid market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the cGMP Plasmid market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the cGMP Plasmid market.
Market Overview: The report provides a comprehensive overview of the cGMP Plasmid market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Standard, Ultra-Pure), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the cGMP Plasmid market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the cGMP Plasmid market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the cGMP Plasmid market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the cGMP Plasmid market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the cGMP Plasmid market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the cGMP Plasmid market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for cGMP Plasmid, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the cGMP Plasmid market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
cGMP Plasmid market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Standard
Ultra-Pure
Market segment by Application
DNA Vaccine
Commercial Virus Vector Manufacturing
Global cGMP Plasmid Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Aldevron
Thermo Fisher
GenScript ProBio
Charles River
WuXi Biologics
Esco Aster
VGXI
Akron Bio
Andelyn Biosciences
Waisman Biomanufacturing
PackGene
Outline of Major Chapters:
Chapter 1: Introduces the definition of cGMP Plasmid, market overview.
Chapter 2: Global cGMP Plasmid market size in revenue.
Chapter 3: Detailed analysis of cGMP Plasmid company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of cGMP Plasmid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 cGMP Plasmid Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global cGMP Plasmid Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global cGMP Plasmid Overall Market Size
2.1 Global cGMP Plasmid Market Size: 2022 VS 2029
2.2 Global cGMP Plasmid Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top cGMP Plasmid Players in Global Market
3.2 Top Global cGMP Plasmid Companies Ranked by Revenue
3.3 Global cGMP Plasmid Revenue by Companies
3.4 Top 3 and Top 5 cGMP Plasmid Companies in Global Market, by Revenue in 2022
3.5 Global Companies cGMP Plasmid Product Type
3.6 Tier 1, Tier 2 and Tier 3 cGMP Plasmid Players in Global Market
3.6.1 List of Global Tier 1 cGMP Plasmid Companies
3.6.2 List of Global Tier 2 and Tier 3 cGMP Plasmid Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global cGMP Plasmid Market Size Markets, 2022 & 2029
4.1.2 Standard
4.1.3 Ultra-Pure
4.2 By Type – Global cGMP Plasmid Revenue & Forecasts
4.2.1 By Type – Global cGMP Plasmid Revenue, 2018-2023
4.2.2 By Type – Global cGMP Plasmid Revenue, 2024-2029
4.2.3 By Type – Global cGMP Plasmid Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global cGMP Plasmid Market Size, 2022 & 2029
5.1.2 DNA Vaccine
5.1.3 Commercial Virus Vector Manufacturing
5.2 By Application – Global cGMP Plasmid Revenue & Forecasts
5.2.1 By Application – Global cGMP Plasmid Revenue, 2018-2023
5.2.2 By Application – Global cGMP Plasmid Revenue, 2024-2029
5.2.3 By Application – Global cGMP Plasmid Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global cGMP Plasmid Market Size, 2022 & 2029
6.2 By Region – Global cGMP Plasmid Revenue & Forecasts
6.2.1 By Region – Global cGMP Plasmid Revenue, 2018-2023
6.2.2 By Region – Global cGMP Plasmid Revenue, 2024-2029
6.2.3 By Region – Global cGMP Plasmid Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America cGMP Plasmid Revenue, 2018-2029
6.3.2 US cGMP Plasmid Market Size, 2018-2029
6.3.3 Canada cGMP Plasmid Market Size, 2018-2029
6.3.4 Mexico cGMP Plasmid Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe cGMP Plasmid Revenue, 2018-2029
6.4.2 Germany cGMP Plasmid Market Size, 2018-2029
6.4.3 France cGMP Plasmid Market Size, 2018-2029
6.4.4 U.K. cGMP Plasmid Market Size, 2018-2029
6.4.5 Italy cGMP Plasmid Market Size, 2018-2029
6.4.6 Russia cGMP Plasmid Market Size, 2018-2029
6.4.7 Nordic Countries cGMP Plasmid Market Size, 2018-2029
6.4.8 Benelux cGMP Plasmid Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia cGMP Plasmid Revenue, 2018-2029
6.5.2 China cGMP Plasmid Market Size, 2018-2029
6.5.3 Japan cGMP Plasmid Market Size, 2018-2029
6.5.4 South Korea cGMP Plasmid Market Size, 2018-2029
6.5.5 Southeast Asia cGMP Plasmid Market Size, 2018-2029
6.5.6 India cGMP Plasmid Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America cGMP Plasmid Revenue, 2018-2029
6.6.2 Brazil cGMP Plasmid Market Size, 2018-2029
6.6.3 Argentina cGMP Plasmid Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa cGMP Plasmid Revenue, 2018-2029
6.7.2 Turkey cGMP Plasmid Market Size, 2018-2029
6.7.3 Israel cGMP Plasmid Market Size, 2018-2029
6.7.4 Saudi Arabia cGMP Plasmid Market Size, 2018-2029
6.7.5 UAE cGMP Plasmid Market Size, 2018-2029
7 cGMP Plasmid Companies Profiles
7.1 Aldevron
7.1.1 Aldevron Company Summary
7.1.2 Aldevron Business Overview
7.1.3 Aldevron cGMP Plasmid Major Product Offerings
7.1.4 Aldevron cGMP Plasmid Revenue in Global Market (2018-2023)
7.1.5 Aldevron Key News & Latest Developments
7.2 Thermo Fisher
7.2.1 Thermo Fisher Company Summary
7.2.2 Thermo Fisher Business Overview
7.2.3 Thermo Fisher cGMP Plasmid Major Product Offerings
7.2.4 Thermo Fisher cGMP Plasmid Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Key News & Latest Developments
7.3 GenScript ProBio
7.3.1 GenScript ProBio Company Summary
7.3.2 GenScript ProBio Business Overview
7.3.3 GenScript ProBio cGMP Plasmid Major Product Offerings
7.3.4 GenScript ProBio cGMP Plasmid Revenue in Global Market (2018-2023)
7.3.5 GenScript ProBio Key News & Latest Developments
7.4 Charles River
7.4.1 Charles River Company Summary
7.4.2 Charles River Business Overview
7.4.3 Charles River cGMP Plasmid Major Product Offerings
7.4.4 Charles River cGMP Plasmid Revenue in Global Market (2018-2023)
7.4.5 Charles River Key News & Latest Developments
7.5 WuXi Biologics
7.5.1 WuXi Biologics Company Summary
7.5.2 WuXi Biologics Business Overview
7.5.3 WuXi Biologics cGMP Plasmid Major Product Offerings
7.5.4 WuXi Biologics cGMP Plasmid Revenue in Global Market (2018-2023)
7.5.5 WuXi Biologics Key News & Latest Developments
7.6 Esco Aster
7.6.1 Esco Aster Company Summary
7.6.2 Esco Aster Business Overview
7.6.3 Esco Aster cGMP Plasmid Major Product Offerings
7.6.4 Esco Aster cGMP Plasmid Revenue in Global Market (2018-2023)
7.6.5 Esco Aster Key News & Latest Developments
7.7 VGXI
7.7.1 VGXI Company Summary
7.7.2 VGXI Business Overview
7.7.3 VGXI cGMP Plasmid Major Product Offerings
7.7.4 VGXI cGMP Plasmid Revenue in Global Market (2018-2023)
7.7.5 VGXI Key News & Latest Developments
7.8 Akron Bio
7.8.1 Akron Bio Company Summary
7.8.2 Akron Bio Business Overview
7.8.3 Akron Bio cGMP Plasmid Major Product Offerings
7.8.4 Akron Bio cGMP Plasmid Revenue in Global Market (2018-2023)
7.8.5 Akron Bio Key News & Latest Developments
7.9 Andelyn Biosciences
7.9.1 Andelyn Biosciences Company Summary
7.9.2 Andelyn Biosciences Business Overview
7.9.3 Andelyn Biosciences cGMP Plasmid Major Product Offerings
7.9.4 Andelyn Biosciences cGMP Plasmid Revenue in Global Market (2018-2023)
7.9.5 Andelyn Biosciences Key News & Latest Developments
7.10 Waisman Biomanufacturing
7.10.1 Waisman Biomanufacturing Company Summary
7.10.2 Waisman Biomanufacturing Business Overview
7.10.3 Waisman Biomanufacturing cGMP Plasmid Major Product Offerings
7.10.4 Waisman Biomanufacturing cGMP Plasmid Revenue in Global Market (2018-2023)
7.10.5 Waisman Biomanufacturing Key News & Latest Developments
7.11 PackGene
7.11.1 PackGene Company Summary
7.11.2 PackGene Business Overview
7.11.3 PackGene cGMP Plasmid Major Product Offerings
7.11.4 PackGene cGMP Plasmid Revenue in Global Market (2018-2023)
7.11.5 PackGene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
